Roche, Summit collaborate to provide personalized cancer care

July 14, 2020—Roche and Summit Cancer Centers will collaborate to explore the use of clinical decision support tools and artificial intelligence–type approaches to the management of patient health information.

Summit (Spokane, Wash.) is an independent, physician-run integrated cancer care network with locations throughout eastern Washington and Idaho. The initial phase of the collaboration will be to implement Roche’s Navify Tumor Board software to automatically pull relevant patient health data and other information from fragmented sources and compile a single, holistic patient dashboard to facilitate Summit’s multidisciplinary tumor board discussions. The software will integrate with the OncoEMR electronic medical record system, which Summit uses in its network, to include comprehensive, longitudinal patient health information in the tumor board review.

“This collaboration with Roche will help advance our mission to treat the whole person with cancer, rather than only the cancer itself,” Arvind Chaudhry, MD, PhD, director of Summit Cancer Centers, said in a press statement. “We believe every patient’s case should be presented to a tumor board, but it can be a challenge to organize the extensive amount of data. The innovative digital approaches we are exploring with Roche can compile and streamline the information to make tumor boards more efficient and more relevant for the participants.”